Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
ER ›
ERAZABAN
Trademark search for:
ERAZABAN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2008-04-23 — Application filed
2009-01-06 — Sn assigned for sect 66a appl from ib
2009-01-07 — Application filed
2009-01-07 — Assigned to examiner
2009-01-13 — Application filed
2009-01-15 — Assigned to examiner
2009-01-16 — Final disposition recorded
2009-01-17 — Office action issued
2009-01-21 — Office action issued
2009-01-21 — Office action issued
2009-02-13 — Office action issued
2009-07-08 — Application abandoned
2009-07-09 — Application abandoned
2009-07-09 — Application abandoned
2010-06-03 — Notification of possible opposition sent to ib
2010-06-03 — Notification of possible opposition created, to be sent to ib
2010-07-09 — Final disposition recorded
2010-07-09 — Final disposition recorded
2010-07-29 — Change of owner received from ib
2010-09-13 — Notification of possible opposition - processed by ib
2010-10-02 — Final disposition recorded
2017-08-25 — New representative at ib received
2017-09-14 — New representative at ib received
2017-10-26 — Change of name/address rec'd from ib
2018-04-23 — Final status recorded
2018-11-23 — Death of international registration
2018-11-24 — Notification of effect of cancellation of intl reg mailed
Owner Information
Dr. Regenold GmbH
DE
HBI No. 1 Limited
GB
Correspondent
KILBURN & STRODE 20 Red Lion Street London WC1R 4PJ, UNITED KINGDOM
Filing Details
Filing Date:
2008-04-23
Status Date:
2018-04-23
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.